Tilak Healthcare is a France-based startup focused on transforming the way chronic eye conditions are monitored. Founded in 2016 by Pr. José-Alain Sahel, an ophthalmologist, and Edouard Gasser, ex-Gameloft, the company's mission is to empower patients and their doctors with easy-to-use apps for disease management. Their product, OdySight, marks a significant breakthrough as the world's first medical mobile app for vision monitoring supported by a national healthcare system. Since its launch in 2018, OdySight has been prescribed to 15,000 patients, primarily in France, and is available in 5 languages, accessible through app stores in France, Spain, Belgium, and the US. The company secured a €10.00M Series A investment on 12 October 2023, with participation from prominent investors including Adelie Capital, Elaia, iBionext, Swen Capital Partners, Laboratoires Théa, Matmut, CapHorn Invest, and Yann Fleureau. The company's unique combination of medical expertise and gaming mastery has positioned it at the intersection of the gaming, healthcare, and medical devices industries, making it an intriguing prospect for potential investors.